| http://www.w3.org/ns/prov#value | - 05Heuer Josef G.Method for reducing morbidity and mortality in critically ill patientsUS20070036806Jun 10, 2004Feb 15, 2007Eli Lilly And Companyhave an increased half-life, decreased immunogenicity, and reduce effector activity; diabetes, obesity, irritable bowel syndrome and other conditions that would be benefited by lowering plasma glucose, inhibiting gastric and/or intestinal motility and inhi
|
